市場調査レポート

商品コード

1657987

術中放射線療法市場の評価、製品・サービス別、技術別、用途別、最終用途別、地域別、機会および予測、2018-2032年

Intraoperative Radiation Therapy Market Assessment, By Products and Services, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F

出版日: 2025年02月19日
発行: Market Xcel - Markets and Data
ページ情報: 英文 235 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 648,270円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 821,142円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,181,292円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の術中放射線療法市場は、予測期間2025-2032年にCAGR 6.10％を記録し、2024年の601億5,000万米ドルから2032年には966億米ドルに成長すると予測されています。同市場の成長を後押ししているのは、新規技術ソリューション開発に向けた投資の増加、がん患者の増加、政府による支援政策やイニシアチブの導入、高齢化人口の拡大、術中放射線療法の受け入れ拡大などです。

世界中のさまざまな政府が自国のヘルスケア・インフラの強化にますます投資しており、術中放射線療法市場の拡大にプラスの影響を与えています。例えば、サウジアラビア政府は「ビジョン2030」プログラムの下、ヘルスケア機器とサービスの近代化、ヘルスケア施設へのアクセス改善、民間部門からの投資の役割拡大に注力しています。このような取り組みにより、術中放射線療法を含む高度な治療ソリューションやサービスへのニーズが高まり、市場に有利な成長機会がもたらされると期待されています。

また、術中放射線療法の臨床試験を重視する傾向が強まっていることも、市場の拡大を後押ししています。臨床試験によって治療プロトコルが確立され、術中放射線療法に対する信頼が高まっているからです。また、臨床試験により、患者の予後改善、正常組織への被曝の最小化、治療間隔の短縮など、術中放射線療法のさまざまな利点が実証されています。

技術的に進歩した画像処理プロセスへの投資が増加しているため、外科手術中に腫瘍を正確に狙い撃ちして可視化する画像ソリューションが開発され、術中放射線療法の有効性と精度が向上しています。このような取り組みは、術中放射線療法の採用をさらに促進し、市場の拡大にプラスの影響を与えています。

さらに、最近の研究や知見では、術中放射線療法を手術や化学療法と組み合わせることで治療成績が向上することも示されており、医療関係者や患者への訴求力が高まっています。術中放射線療法は周辺組織の健康へのダメージを最小限に抑えるため、その普及は急速に進んでいます。

市場規模の分析と予測
- 金額別
市場シェア分析と予測
- 製品・サービス別
  - 製品
  - サービス
- 技術別
  - 電子IORT
  - 術中小線源治療
- 用途別
  - 乳がん
  - 脳腫瘍
  - 消化器がん
  - 頭頸部がん
  - 大腸がん
  - 子宮頸がん
  - 肺がん
  - その他のがん
- 最終用途別
  - 病院
  - 専門クリニック
  - その他
- 地域別
  - 北米
  - 欧州
  - アジア太平洋
  - 南米
  - 中東およびアフリカ
- 企業別市場シェア分析（上位5社およびその他- 金額別、2024年）
市場マップ分析、2024年
- 製品・サービス別
- 技術別
- 用途別
- 最終用途別
- 地域別

第5章北米の術中放射線療法市場の展望、2018年～2032年*

市場規模の分析と予測
- 金額別
市場シェア分析と予測
- 製品・サービス別
  - 製品
  - サービス
- 技術別
  - 電子IORT
  - 術中小線源治療
- 用途別
  - 乳がん
  - 脳腫瘍
  - 消化器がん
  - 頭頸部がん
  - 大腸がん
  - 子宮頸がん
  - 肺がん
  - その他のがん
- 最終用途別
  - 病院
  - 専門クリニック
  - その他
- 国別シェア
  - 米国
  - カナダ
  - メキシコ
国別市場評価
- 米国の術中放射線療法市場の見通し、2018年～2032年*
  - 市場規模の分析と予測
  - 市場シェア分析と予測
- カナダ
- メキシコ

すべてのセグメントは、対象となるすべての地域と国で提供されます。

第6章欧州の術中放射線療法市場の展望、2018年～2032年

ドイツ
フランス
イタリア
英国
ロシア
オランダ
スペイン
ポーランド

第7章アジア太平洋の術中放射線療法市場の展望、2018年～2032年

インド
中国
日本
オーストラリア
ベトナム
韓国
インドネシア
フィリピン

第8章南米の術中放射線療法市場の展望、2018年～2032年

ブラジル
アルゼンチン

第9章中東およびアフリカの術中放射線療法市場の見通し、2018年～2032年

サウジアラビア
アラブ首長国連邦
南アフリカ
イスラエル

第10章需要供給分析

第11章バリューチェーン分析

第12章ポーターのファイブフォース分析

第13章 PESTLE分析

第14章価格分析

第15章市場力学

市場促進要因
市場の課題

第16章市場の動向と発展

第17章規制枠組みとイノベーション

臨床試験
規制当局の承認
開発と革新

第18章特許の情勢

第19章ケーススタディ

第20章競合情勢

市場リーダー上位5社の競合マトリックス
トップ5企業のSWOT分析
市場トップ10の主要企業の情勢
- Eckert &Ziegler SE
- Varian Medical Systems, Inc.
- Elekta AB
- Sensus Healthcare, Inc.
- IntraOp Medical, Inc.
- Perspective Therapeutics Inc.
- Becton, Dickinson and Company
- Sordina IORT Technologies SpA
- IsoAid, LLC
- Ariane Medical Systems Ltd.

上記の企業は市場シェアに基づいて注文を保留しておらず、調査作業中に入手可能な情報に基づいて変更される可能性があります。

第21章戦略的提言

第22章調査会社について・免責事項

図表

List of Tables

Table 1. Competition Matrix of Top 5 Market Leaders
Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 2. Global Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 3. Global Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 4. Global Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 5. Global Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 6. Global Intraoperative Radiation Therapy Market Share (%), By Region, 2018-2032F
Figure 7. North America Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 8. North America Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 9. North America Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 10. North America Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 11. North America Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 12. North America Intraoperative Radiation Therapy Market Share (%), By Country, 2018-2032F
Figure 13. United States Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 14. United States Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 15. United States Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 16. United States Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 17. United States Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 18. Canada Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 19. Canada Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 20. Canada Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 21. Canada Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 22. Canada Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 23. Mexico Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 24. Mexico Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 25. Mexico Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 26. Mexico Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 27. Mexico Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 28. Europe Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 29. Europe Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 30. Europe Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 31. Europe Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 32. Europe Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 33. Europe Intraoperative Radiation Therapy Market Share (%), By Country, 2018-2032F
Figure 34. Germany Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 35. Germany Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 36. Germany Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 37. Germany Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 38. Germany Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 39. France Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 40. France Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 41. France Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 42. France Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 43. France Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 44. Italy Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 45. Italy Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 46. Italy Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 47. Italy Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 48. Italy Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 49. United Kingdom Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 50. United Kingdom Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 51. United Kingdom Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 52. United Kingdom Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 53. United Kingdom Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 54. Russia Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 55. Russia Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 56. Russia Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 57. Russia Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 58. Russia Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 59. Netherlands Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 60. Netherlands Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 61. Netherlands Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 62. Netherlands Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 63. Netherlands Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 64. Spain Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 65. Spain Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 66. Spain Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 67. Spain Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 68. Spain Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 69. Turkey Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 70. Turkey Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 71. Turkey Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 72. Turkey Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 73. Turkey Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 74. Poland Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 75. Poland Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 76. Poland Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 77. Poland Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 78. Poland Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 79. South America Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 80. South America Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 81. South America Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 82. South America Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 83. South America Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 84. South America Intraoperative Radiation Therapy Market Share (%), By Country, 2018-2032F
Figure 85. Brazil Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 86. Brazil Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 87. Brazil Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 88. Brazil Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 89. Brazil Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 90. Argentina Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 91. Argentina Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 92. Argentina Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 93. Argentina Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 94. Argentina Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 95. Asia-Pacific Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 96. Asia-Pacific Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 97. Asia-Pacific Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 98. Asia-Pacific Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 99. Asia-Pacific Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 100. Asia-Pacific Intraoperative Radiation Therapy Market Share (%), By Country, 2018-2032F
Figure 101. India Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 102. India Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 103. India Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 104. India Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 105. India Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 106. China Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 107. China Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 108. China Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 109. China Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 110. China Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 111. Japan Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 112. Japan Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 113. Japan Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 114. Japan Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 115. Japan Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 116. Australia Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 117. Australia Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 118. Australia Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 119. Australia Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 120. Australia Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 121. Vietnam Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 122. Vietnam Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 123. Vietnam Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 124. Vietnam Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 125. Vietnam Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 126. South Korea Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 127. South Korea Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 128. South Korea Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 129. South Korea Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 130. South Korea Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 131. Indonesia Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 132. Indonesia Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 133. Indonesia Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 134. Indonesia Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 135. Indonesia Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 136. Philippines Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 137. Philippines Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 138. Philippines Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 139. Philippines Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 140. Philippines Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 141. Middle East & Africa Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 142. Middle East & Africa Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 143. Middle East & Africa Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 144. Middle East & Africa Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 145. Middle East & Africa Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 146. Middle East & Africa Intraoperative Radiation Therapy Market Share (%), By Country, 2018-2032F
Figure 147. Saudi Arabia Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 148. Saudi Arabia Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 149. Saudi Arabia Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 150. Saudi Arabia Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 151. Saudi Arabia Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 152. UAE Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 153. UAE Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 154. UAE Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 155. UAE Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 156. UAE Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 157. South Africa Intraoperative Radiation Therapy Market, By Value, In USD Million, 2018-2032F
Figure 158. South Africa Intraoperative Radiation Therapy Market Share (%), By Products and Services, 2018-2032F
Figure 159. South Africa Intraoperative Radiation Therapy Market Share (%), By Technology, 2018-2032F
Figure 160. South Africa Intraoperative Radiation Therapy Market Share (%), By Application, 2018-2032F
Figure 161. South Africa Intraoperative Radiation Therapy Market Share (%), By End-user, 2018-2032F
Figure 162. By Products and Services Map-Market Size (USD Million) & Growth Rate (%), 2024
Figure 163. By Technology Map-Market Size (USD Million) & Growth Rate (%), 2024
Figure 164. By Application Map-Market Size (USD Million) & Growth Rate (%), 2024
Figure 165. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2024
Figure 166. By Region Map-Market Size (USD Million) & Growth Rate (%), 2024

Product Code: MX12769

Global intraoperative radiation therapy market is projected to witness a CAGR of 6.10% during the forecast period 2025-2032, growing from USD 60.15 billion in 2024 to USD 96.60 billion in 2032. The market's growth is augmented by the increasing investments towards developing novel technological solutions, rising cancer cases, the introduction of supportive government policies and initiatives, expansion of the ageing population, and increasing acceptance of intraoperative radiation therapy.

Various governments across the globe are increasingly investing in enhancing their country's healthcare infrastructure, positively influencing the expansion of the intraoperative radiation therapy market. For instance, under the Vision 2030 program, the government of Saudi Arabia is focusing on the modernization of healthcare equipment and services, improving access to healthcare facilities, and increasing the role of investments from the private sector. Such efforts are expected to bolster the requirement for advanced therapeutic solutions and services including intraoperative radiation therapy and provide lucrative growth opportunities for the market.

Growing emphasis on clinical trials for intraoperative radiation therapy is also supporting the market's expansion as clinical trials are allowing the establishment of treatment protocols and increasing confidence in the procedure. Clinical trials have also demonstrated the various benefits of intraoperative radiation therapy including improved patient outcomes, minimal exposure to normal tissues, and limited treatment intervals.

Rising investments towards technologically advanced imaging processes are allowing the development of imaging solutions that aid in the precise targeting and visualization of tumors during surgical procedures, enhancing the efficacy and precision of intraoperative radiation therapy. Such efforts are further augmenting the adoption of the procedure and positively influencing the expansion of the market.

Moreover, recent studies and findings have also shown that combining intraoperative radiation therapy with surgery and chemotherapy improves treatment outcomes, increasing its appeal to medical professionals and patients. The deployment of intraoperative radiation therapy is rapidly soaring as the procedure minimizes the damage caused to the health of surrounding tissues.

Surging Investments in Healthcare Infrastructure and Oncology Research

The growing emphasis on enhancing healthcare infrastructure and cancer research activities is another major factor supporting the growth of the global intraoperative radiation therapy market. Various public and private healthcare institutions and governments are significantly investing towards expanding oncology treatment centers and integrating advanced treatment options including novel radiation therapy technologies. As the healthcare sector witnesses the upgradation of technology and expansion of capabilities, the acceptance and adoption of intraoperative radiation therapy are expected to increase significantly.

Additionally, various researchers are being rewarded with grants to improve cancer treatments, further providing lucrative growth opportunities for the market by fostering innovation and augmenting the availability of advanced treatment options. For instance, in January 2025, two projects led by the University of Wollongong's (UOW) Centre for Medical Radiation Physics (CMRP), were awarded over USD 2 million in funding from the National Health Medical Research Centre (NHMRC). Such efforts improve patient outcomes while supporting the rising adoption of innovative radiation therapies in different clinical settings.

Robust Product Pipeline and Promising Clinical Trials Support Market Expansion

The rising number of clinical trials for intraoperative radiation therapy is bolstering the growth of the market as they aid in propelling the applications of intraoperative radiation therapy for various types of cancer such as colorectal, lung, breast, and brain, among others. Additionally, clinical trials also play a crucial role in showcasing the various benefits associated with intraoperative radiation therapy as opposed to conventional radiotherapy. Thus, various healthcare companies, cancer research institutes, and research organizations are significantly investing in clinical trials.

For instance, the University of California is conducting an interventional study to evaluate the side effects of intraoperative radiation therapy and its effectiveness in patients suffering from breast cancer who are undergoing breast-conserving surgery. The study is expected to conclude in December 2028 with a primary objective of systemically assessing long-term and acute toxicity, and outcomes of intraoperative radiation therapy in a broader cohort of patients.

Breast Cancer Accounts for Significant Share of the Market

Breast cancer treatment is expected to account for a significant share of the market over the forecast period owing to the increasing acceptance of intraoperative radiation therapy in comparison to conventional radiation therapy for treating early-stage breast cancer. After the removal of the cancer cells from the breast, the intraoperative radiation therapy machine is placed at an appropriate location for determining the required dosage for radiation based on evidence-based guidelines. The radiation is aimed at where the risk of cancer recurrence is the highest.

Due to the rising prevalence of the condition, the demand for effective treatment options that eliminate or reduce the chances of cancer recurrence is significantly increasing. As per the estimates of the National Breast Cancer Foundation, in 2024, 2,800 men and 310,720 women were diagnosed with invasive breast cancer in the United States. The foundation also estimates that approximately 1 in 8 women in the country will be diagnosed with breast cancer during their lifetime. Thus, various medical device and pharmaceutical companies are focusing on collaborating with oncology centers to commercialize and develop intraoperative radiation therapy solutions for breast cancer, further providing lucrative growth opportunities for the market.

North America Region Holds Major Market Share

The expansion of the North America intraoperative radiation therapy market can be attributed to the increasing incidences of cancer, the rising availability of advanced therapeutic solutions, and growing investments in the healthcare sector. According to the statistics released by the National Cancer Institute in May 2024, approximately 2,001,140 new cancer cases were expected to be diagnosed in the United States in 2024. Additionally, the growing preference for minimally invasive procedures in the region is also bolstering the demand for intraoperative radiation therapy. The therapeutic procedure allows the delivery of a high dose of radiation at the tumor bed during the surgical procedure, reducing the duration of the treatment and improving patient outcomes.

Additionally, the strong presence of leading research institutions and market players supports the market's expansion in North America as they significantly invest in research and development activities, ensuring the availability of advanced treatment options in countries such as the United States and Canada. Furthermore, the increasing awareness among the patient population and healthcare professionals about the various advantages of intraoperative radiation therapies is also augmenting their adoption in North America. Healthcare institutions across the region are actively investing in training medical professionals on using intraoperative radiation therapy.

Future Market Scenario (2025 - 2032F)

As per the global intraoperative radiation therapy market analysis, the market is expected to witness significant growth over the forecast period due to the rapid expansion of the healthcare industry, increasing preference for minimally invasive technologies, rising cases of cancer, and growing focus on the development of advanced therapeutic solutions.

According to the estimates of the American Cancer Society, the number of cases of cancer is expected to reach 35 million, by 2050. This increase is expected to bolster the utilization of intraoperative radiation therapy as the procedure uses innovative equipment for delivering intraoperative radiation therapy, electron beams, or x-rays directly, immediately eliminating cancer cells after the surgery.

Technological innovations including electronic brachytherapy devices and mobile line accelerators are enhancing the accessibility and efficacy of intraoperative radiation therapy systems. Such advancements are expected to aid in precisely targeting tumor cells during surgical procedures, ensuring improved patient outcomes due to minimization of damage caused to healthy tissues.

The increasing efforts of governments of various countries to enhance their healthcare sector and boost the availability of advanced medical technologies are also expected to provide lucrative growth opportunities for the market.

Key Players Landscape and Outlook

The market's key players are actively engaging in mergers and acquisitions to strengthen their position and ensure the availability of advanced technologies in various regions across the globe. In February 2023, Viewpoint Molecular Targeting, Inc. and Isoray, Inc. announced the successful completion of their merger. The companies adopted a new name Perspective Therapeutics Inc. and are focusing on the advancing of cancer treatments with the help of imaging technologies, radiopharmaceuticals, and radiation therapies. Perspective Therapeutics is also developing a novel pipeline of proprietary targeting peptides for diagnosing tumors and delivering Targeted Alpha Therapies (TATs).

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Intraoperative Radiation Therapy Market Outlook, 2018-2032F

4.1. Market Size Analysis & Forecast
- 4.1.1. By Value
4.2. Market Share Analysis & Forecast
- 4.2.1. By Products and Services
  - 4.2.1.1. Products
    - 4.2.1.1.1. Systems/Accelerators
    - 4.2.1.1.2. Applicators and Afterloaders
    - 4.2.1.1.3. Treatment Planning Systems
    - 4.2.1.1.4. Accessories
  - 4.2.1.2. Services
- 4.2.2. By Technology
  - 4.2.2.1. Electron IORT
  - 4.2.2.2. Intraoperative Brachytherapy
- 4.2.3. By Application
  - 4.2.3.1. Breast Cancer
  - 4.2.3.2. Brain Tumor
  - 4.2.3.3. Gastrointestinal Cancer
  - 4.2.3.4. Head and Neck Cancer
  - 4.2.3.5. Colorectal Cancer
  - 4.2.3.6. Cervical Cancer
  - 4.2.3.7. Lung Cancer
  - 4.2.3.8. Other Cancer Types
- 4.2.4. By End-user
  - 4.2.4.1. Hospitals
  - 4.2.4.2. Specialty Clinics
  - 4.2.4.3. Others
- 4.2.5. By Region
  - 4.2.5.1. North America
  - 4.2.5.2. Europe
  - 4.2.5.3. Asia-Pacific
  - 4.2.5.4. South America
  - 4.2.5.5. Middle East and Africa
- 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
4.3. Market Map Analysis, 2024
- 4.3.1. By Products and Services
- 4.3.2. By Technology
- 4.3.3. By Application
- 4.3.4. By End-user
- 4.3.5. By Region

5. North America Intraoperative Radiation Therapy Market Outlook, 2018-2032F*

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
5.2. Market Share Analysis & Forecast
- 5.2.1. By Products and Services
  - 5.2.1.1. Products
    - 5.2.1.1.1. Systems/Accelerators
    - 5.2.1.1.2. Applicators and Afterloaders
    - 5.2.1.1.3. Treatment Planning Systems
    - 5.2.1.1.4. Accessories
  - 5.2.1.2. Services
- 5.2.2. By Technology
  - 5.2.2.1. Electron IORT
  - 5.2.2.2. Intraoperative Brachytherapy
- 5.2.3. By Application
  - 5.2.3.1. Breast Cancer
  - 5.2.3.2. Brain Tumor
  - 5.2.3.3. Gastrointestinal Cancer
  - 5.2.3.4. Head and Neck Cancer
  - 5.2.3.5. Colorectal Cancer
  - 5.2.3.6. Cervical Cancer
  - 5.2.3.7. Lung Cancer
  - 5.2.3.8. Other Cancer Types
- 5.2.4. By End-user
  - 5.2.4.1. Hospitals
  - 5.2.4.2. Specialty Clinics
  - 5.2.4.3. Others
- 5.2.5. By Country Share
  - 5.2.5.1. United States
  - 5.2.5.2. Canada
  - 5.2.5.3. Mexico
5.3. Country Market Assessment
- 5.3.1. United States Intraoperative Radiation Therapy Market Outlook, 2018-2032F*
  - 5.3.1.1. Market Size Analysis & Forecast
    - 5.3.1.1.1. By Value
  - 5.3.1.2. Market Share Analysis & Forecast
    - 5.3.1.2.1. By Products and Services
      - 5.3.1.2.1.1. Products
      - 5.3.1.2.1.1.1. Systems/Accelerators
      - 5.3.1.2.1.1.2. Applicators and Afterloaders
      - 5.3.1.2.1.1.3. Treatment Planning Systems
      - 5.3.1.2.1.1.4. Accessories
      - 5.3.1.2.1.2. Services
    - 5.3.1.2.2. By Technology
      - 5.3.1.2.2.1. Electron IORT
      - 5.3.1.2.2.2. Intraoperative Brachytherapy
    - 5.3.1.2.3. By Application
      - 5.3.1.2.3.1. Breast Cancer
      - 5.3.1.2.3.2. Brain Tumor
      - 5.3.1.2.3.3. Gastrointestinal Cancer
      - 5.3.1.2.3.4. Head and Neck Cancer
      - 5.3.1.2.3.5. Colorectal Cancer
      - 5.3.1.2.3.6. Cervical Cancer
      - 5.3.1.2.3.7. Lung Cancer
      - 5.3.1.2.3.8. Other Cancer Types
    - 5.3.1.2.4. By End-user
      - 5.3.1.2.4.1. Hospitals
      - 5.3.1.2.4.2. Specialty Clinics
      - 5.3.1.2.4.3. Others
- 5.3.2. Canada
- 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Intraoperative Radiation Therapy Market Outlook, 2018-2032F

6.1. Germany
6.2. France
6.3. Italy
6.4. United Kingdom
6.5. Russia
6.6. Netherlands
6.7. Spain
6.8. Poland

7. Asia-Pacific Intraoperative Radiation Therapy Market Outlook, 2018-2032F

7.1. India
7.2. China
7.3. Japan
7.4. Australia
7.5. Vietnam
7.6. South Korea
7.7. Indonesia
7.8. Philippines

8. South America Intraoperative Radiation Therapy Market Outlook, 2018-2032F

8.1. Brazil
8.2. Argentina

9. Middle East and Africa Intraoperative Radiation Therapy Market Outlook, 2018-2032F

9.1. Saudi Arabia
9.2. UAE
9.3. South Africa
9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

15.1. Market Drivers
15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

17.1. Clinical Trials
17.2. Regulatory Approvals
17.3. Developments and Innovations

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

20.1. Competition Matrix of Top 5 Market Leaders
20.2. SWOT Analysis for Top 5 Players
20.3. Key Players Landscape for Top 10 Market Players
- 20.3.1. Eckert & Ziegler SE
  - 20.3.1.1. Company Details
  - 20.3.1.2. Key Management Personnel
  - 20.3.1.3. Products and Services
  - 20.3.1.4. Financials (As Reported)
  - 20.3.1.5. Key Market Focus and Geographical Presence
  - 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
- 20.3.2. Varian Medical Systems, Inc.
- 20.3.3. Elekta AB
- 20.3.4. Sensus Healthcare, Inc.
- 20.3.5. IntraOp Medical, Inc.
- 20.3.6. Perspective Therapeutics Inc.
- 20.3.7. Becton, Dickinson and Company
- 20.3.8. Sordina IORT Technologies S.p.A.
- 20.3.9. IsoAid, LLC
- 20.3.10. Ariane Medical Systems Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

術中放射線療法市場の評価、製品・サービス別、技術別、用途別、最終用途別、地域別、機会および予測、2018-2032年

Intraoperative Radiation Therapy Market Assessment, By Products and Services, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の術中放射線療法市場の展望、2018年～2032年

第5章 北米の術中放射線療法市場の展望、2018年～2032年*

第6章 欧州の術中放射線療法市場の展望、2018年～2032年

第7章 アジア太平洋の術中放射線療法市場の展望、2018年～2032年

第8章 南米の術中放射線療法市場の展望、2018年～2032年

第9章 中東およびアフリカの術中放射線療法市場の見通し、2018年～2032年

第10章 需要供給分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析